Biosimilars: Strategies for AU market entry

Sep 16, 2022

Pearce IP’s Naomi Pearce speaks to Kate Legge about the key IP strategies to enable the launch of biosimilars around the world, with a particular focus on Australia.  Offering practical tips to success for biosimilar companies, this 14 minute PiPCast touches on:

  • biosimilar FTO/clearance strategies, litigation, and settlement strategies;
  • key lessons learned from the 11 AbbVie global royalty bearing deals relating to adalimumab (Humira®); and
  • Australian biosimilar litigations.
Print Page Mail Article